Document is current
Any future updates will be listed below
-
Authors
George, Julie
Walter, Vonn
Peifer, Martin https://orcid.org/0000-0002-5243-5503
Alexandrov, Ludmil B. https://orcid.org/0000-0003-3596-4515
Seidel, Danila
Leenders, Frauke
Maas, Lukas
Müller, Christian
Dahmen, Ilona
Delhomme, Tiffany M.
Ardin, Maude
Leblay, Noemie
Byrnes, Graham
Sun, Ruping https://orcid.org/0000-0003-3702-9483
De Reynies, Aurélien
McLeer-Florin, Anne
Bosco, Graziella
Malchers, Florian
Menon, Roopika
Altmüller, Janine
Becker, Christian
Nürnberg, Peter
Achter, Viktor
Lang, Ulrich
Schneider, Peter M. https://orcid.org/0000-0003-0744-2349
Bogus, Magdalena
Soloway, Matthew G.
Wilkerson, Matthew D.
Cun, Yupeng https://orcid.org/0000-0002-4241-8099
McKay, James D.
Moro-Sibilot, Denis
Brambilla, Christian G.
Lantuejoul, Sylvie
Lemaitre, Nicolas
Soltermann, Alex
Weder, Walter
Tischler, Verena
Brustugun, Odd Terje
Lund-Iversen, Marius
Helland, Åslaug
Solberg, Steinar
Ansén, Sascha
Wright, Gavin https://orcid.org/0000-0002-7000-9305
Solomon, Benjamin
Roz, Luca
Pastorino, Ugo
Petersen, Iver
Clement, Joachim H.
Sänger, Jörg
Wolf, Jürgen
Vingron, Martin https://orcid.org/0000-0002-1765-4241
Zander, Thomas
Perner, Sven
Travis, William D.
Haas, Stefan A.
Olivier, Magali
Foll, Matthieu
Büttner, Reinhard
Hayes, David Neil
Brambilla, Elisabeth
Fernandez-Cuesta, Lynnette
Thomas, Roman K.
- License Information
-
More Information
Article History
Received: 10 April 2017
Accepted: 18 January 2018
First Online: 13 March 2018
Competing interests
: L.F.-C. and R.K.T. are inventors on a patent application related to findings described in this manuscript. R.K.T. is a founder of NEO New Oncology GmbH, now part of Siemens Healthcare. R.K.T. received consulting and lecture fees (Merck, Roche, Lilly, Boehringer Ingelheim, AstraZeneca, Daiichi-Sankyo, MSD, NEO New Oncology, Puma, Clovis). R.B. is a cofounder and owner of Targos Molecular Diagnostics and received honoraria for consulting and lecturing from AstraZeneca, Boehringer Ingelheim, Merck, Roche, Novartis, Lilly, and Pfizer. J.W. received consulting and lecture fees from Roche, Novartis, Boehringer Ingelheim, AstraZeneca, Bayer, Lilly, Merck, Amgen and research support from Roche, Bayer, Novartis, Boehringer Ingelheim. T.Z. received honoraria from Roche, Novartis, Boehringer Ingelheim, Lilly, Merck, Amgen and research support from Novartis. B.S. received consulting fees from AstraZeneca, Roche-Genentech, Pfizer, Novartis, Merck, and Bristol Myers Squibb. The remaining authors declare no competing financial interest.
